Results 31 to 40 of about 2,784 (211)
Buerger’s disease or thromboangiitis obliterans: description of two cases [PDF]
Beyond Rheumatology, 2019 Buerger’s disease, or thromboangiitis obliterans (TAO), is a segmental non-atherosclerotic occlusive inflammatory condition of small arteries and veins of the upper and lower extremities, characterized by thrombosis and recanalization of the affected ...
Carlo Umberto Manzini +2 more
doaj +1 more source
Successful treatment of jellyfish sting-induced severe digital ischemia with intravenous iloprost infusion [PDF]
, 2016 published_or_final_versio
Chan, YC, Law, Y, Cheng, SWK, Lo, ASH
core +1 more source
Thromboangiitis obliterans (Buerger disease)
Radiology Case Reports, 2015 Thromboangiitis obliterans (Buerger disease) is an occlusive, nonatherosclerotic, inflammatory vasculitis that causes ischemia in small and medium vessels. Most commonly, Buerger disease is diagnosed in 40- to 45-year-old men with a heavy smoking history.
Jessica Seebald, BS, Lyndon Gritters, MD
doaj +1 more source
Circulating angiogenic factors in patients with thromboangiitis obliterans. [PDF]
PLoS ONE, 2012 BACKGROUND: Thromboangiitis obliterans (TAO, also known as Buerger's disease) is a non-atherosclerotic inflammatory vascular disease that primarily affects arteries in the extremities of young adult smokers.
Bernd Hewing +5 more
doaj +1 more source
Immunological Changes Related to Smoking in Buerger’s Disease (Thromboangiitis Obliterans): A Systematic Review [PDF]
Disease and DiagnosisThromboangiitis obliterans (TAO), or Buerger’s disease (BD), is a progressive inflammatory condition that affects small and medium arteries, primarily in the limbs, and is strongly associated with tobacco use.
Narges Khaghanzadeh +3 more
doaj +1 more source
Buflomedil for intermittent claudication [PDF]
, 2013 Background : Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease.
De Backer, Tine, Vander Stichele, Robert
core +2 more sources
Chinese Journal of Lung Cancer, 2020 Background and objective To date, there is no effective treatment for thromboangiitis obliterans (TAO). Anlotinib, as a third-line therapy, is recommended for patients with refractory advanced non-small cell lung cancer (NSCLC).
Huijuan HAO +4 more
doaj +1 more source
Treatment of digit ulcers in a patient with Buerger's disease by using cervical spinal cord stimulation -a case report- [PDF]
Korean Journal of Anesthesiology, 2013 Buerger's disease (thromboangiitis obliterans) is known as a segmental inflammatory vasculitis that involves the small-sized and medium-sized arteries, veins, and nerves. Most effective treatment for Buerger's disease is smoking cessation. Except for the
Sang-Wook Ryu +6 more
doaj +1 more source
Thromboangiitis Obliterans (Buerger Disease) [PDF]
Mayo Clinic Proceedings, 2007 A healthy 44-year-old woman presented with a 1month history of diffuse arthralgias followed by skin discoloration of the fingers of both hands that progressed during a 1-week period and was accompanied by resting finger pain exacerbated by exposure to cold. She had a 25-pack-year history of cigarette smoking but no history of illicit drug use.
John A, Batsis, Kulsum K, Casey
openaire +2 more sources
Annals of Internal Medicine: Clinical Cases, 2023 A 22-year-old man presented with recurrent pain and linear redness of the lower extremities for 1 year. He smoked 20 cigarettes daily for 6 years and did not report cannabis use.
Yasutaka Yanagita +3 more
doaj +1 more source